PlainRecalls
FDA Drug Moderate Class II Terminated

Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC 68382-036-16), and c) 1000-count bottles, (NDC 68382-036-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.

Reported: August 24, 2016 Initiated: July 19, 2016 #D-1460-2016

Product Description

Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC 68382-036-16), and c) 1000-count bottles, (NDC 68382-036-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.

Reason for Recall

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Details

Units Affected
223,776 bottles
Distribution
Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC 68382-036-16), and c) 1000-count bottles, (NDC 68382-036-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 223,776 bottles.
Why was this product recalled?
Failed Dissolution Specifications: out of specification dissolution results in retained samples
Which agency issued this recall?
This recall was issued by the FDA Drug on August 24, 2016. Severity: Moderate. Recall number: D-1460-2016.